The recent study achieved its results after looking at 14 studies involving 9,332 people from all over Europe, in which a large number of data was evaluated.
All participants in the evaluation were over the age of 50 and were taking at least one of the following drugs: cholesterol-lowering drugs such as statins, diabetes control drugs including Insulinanti-inflammatory drugs excluding steroids e"levodopa" Treats movement disorders resulting from neurodegenerative diseases.
The results showed that drugs used to lower cholesterol or control diabetes were associated with a lower prevalence of any type of diabetes. eye diseases degenerative, by 15 and 22 percent respectively.
In a press release, the study authors said: "More data is needed to confirm our findings so that more emphasis is placed on the discovery of the causal factor and the potential interference of these drugs with pathophysiological pathways.".
“>
This was reported by the study, the results of which were published in the British Journal ophthalmologythat the study supervised by European Union For epidemiology the eyesconfirmed a close link between the drugs high cholesterol or those used to control disease diabetes Of the second type, the chances of developing age-related macular degeneration decrease.
The recent study achieved its results after looking at 14 studies involving 9,332 people from all over Europe, in which a large number of data was evaluated.
All participants in the evaluation were over the age of 50 and were taking at least one of the following drugs: cholesterol-lowering drugs such as statins, diabetes control drugs including InsulinAnti-inflammatory drugs, with the exception of steroids, and levodopa, which treat movement disorders caused by neurodegenerative diseases.
The results showed that drugs used to lower cholesterol or control diabetes were associated with a lower prevalence of any type of diabetes. eye diseases degenerative, by 15 and 22 percent respectively.
“More data is needed to confirm our findings so that more attention is placed on uncovering the causative factor and potential interference of these drugs with pathophysiological pathways,” the study authors said in a press release.
